+Compare
PMD
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
21.13M

PMD Psychemedics Corp Forecast, Technical & Fundamental Analysis

a provider of drug testing services through hair samples analysis

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for PMD with price predictions
08:00 PM EDT Sep 26, 2023

PMD's RSI Indicator climbs out of oversold territory

The RSI Oscillator for PMD moved out of oversold territory on September 26, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In of the 40 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where PMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PMD just turned positive on September 26, 2023. Looking at past instances where PMD's MACD turned positive, the stock continued to rise in of 58 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

PMD moved below its 50-day moving average on August 22, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PMD crossed bearishly below the 50-day moving average on August 24, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PMD entered a downward trend on September 27, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.315) is normal, around the industry mean (24.916). P/E Ratio (102.041) is within average values for comparable stocks, (79.212). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.219). PMD's Dividend Yield (0.076) is considerably higher than the industry average of (0.019). P/S Ratio (0.884) is also within normal values, averaging (58.139).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.33B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -9%. FEMY experienced the highest price growth at 244%, while RHNMF experienced the biggest fall at -54%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 66
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published Dividends

PMD paid dividends on June 08, 2023

Psychemedics Corp PMD Stock Dividends
А dividend of $0.07 per share was paid with a record date of June 08, 2023, and an ex-dividend date of May 24, 2023. Read more...
A.I. Advisor
published General Information

General Information

a provider of drug testing services through hair samples analysis

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
289 Great Road
Phone
+1 978 206-8220
Employees
133
Web
https://www.psychemedics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRFS1.980.01
+0.51%
BRF - Brasil Foods SA
CCEP62.31-0.36
-0.57%
Coca-Cola Europacific Partners plc
SGMA3.25-0.02
-0.61%
SigmaTron International
CMBM7.03-0.05
-0.71%
Cambium Networks Corp
KREF12.09-0.12
-0.98%
KKR Real Estate Finance Trust

PMD and

Correlation & Price change

A.I.dvisor tells us that PMD and NMRD have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMD and NMRD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMD
1D Price
Change %
PMD100%
-1.07%
NMRD - PMD
26%
Poorly correlated
+0.06%
BBLG - PMD
24%
Poorly correlated
-0.01%
RCEL - PMD
23%
Poorly correlated
+3.90%
SINT - PMD
23%
Poorly correlated
-0.94%
BSX - PMD
22%
Poorly correlated
-1.38%
More

Groups containing PMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMD
1D Price
Change %
PMD100%
-1.07%
Medical Specialties
(undefined stocks)
11%
Poorly correlated
+0.17%
Medical Specialties
(undefined stocks)
11%
Poorly correlated
+0.17%
health
(undefined stocks)
9%
Poorly correlated
+1.00%